Valuation: MiniMed Group, Inc.

Market Cap 5.64B 4.98B 4.71B 4.27B 8B 541B 8.08B 56.48B 21.77B 276B 21.17B 20.71B 889B P/E 2027 *
33.3x
P/E 2028 * 26.8x
Enterprise Value 5.34B 4.71B 4.46B 4.04B 7.58B 512B 7.66B 53.5B 20.62B 262B 20.05B 19.62B 842B EV / Sales 2027 *
1.55x
EV / Sales 2028 * 1.35x
Free-Float
10.08%
Yield 2027 *
-
Yield 2028 * -
1 day-1.12%
1 week-3.75%
Current month-2.42%
1 month-2.42%
3 months+32.24%
6 months+37.77%
1 week 19.71
Extreme 19.71
21.03
1 month 19.65
Extreme 19.65
24.43
Current year 10.65
Extreme 10.65
24.43
1 year 10.65
Extreme 10.65
24.43
3 years 10.65
Extreme 10.65
24.43
5 years 10.65
Extreme 10.65
24.43
10 years 10.65
Extreme 10.65
24.43
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Tax

Chief Executive Officer

-31,350 0.0112%
7/31/26 Tax

Chief Technology Officer

-8,012 0.0029%
7/31/26 Tax

General Counsel

-1,762 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
-1.15%-3.75% - - 5.64B
-1.58%-4.13%-25.92%+3.65% 175B
-0.71%-3.24%-9.27%+11.11% 111B
-1.20%+0.14%-25.94%-0.02% 107B
+1.04%-2.60%-47.08%-10.76% 75.31B
-2.82%-4.68%-4.75%+66.22% 58.7B
-1.07%-1.19%-3.64%-30.03% 49.57B
+1.53%+1.90%+15.16%+55.54% 49.27B
-1.75%+1.04%-17.45%+22.39% 42.02B
-1.27%-2.30%+27.37%-9.35% 32.69B
Average -0.90%-1.17%-10.17%+12.08% 70.62B
Weighted average by Cap. -0.96%-1.17%-16.32%+9.75%

Financials

2027 *2028 *
Net sales 3.44B 3.03B 2.87B 2.6B 4.88B 330B 4.93B 34.43B 13.27B 168B 12.91B 12.63B 542B 3.72B 3.28B 3.11B 2.82B 5.28B 357B 5.34B 37.28B 14.37B 182B 13.98B 13.67B 587B
Net income 171M 151M 143M 130M 243M 16.43B 245M 1.71B 661M 8.39B 643M 629M 26.99B 250M 221M 209M 190M 355M 24.03B 359M 2.51B 967M 12.27B 940M 920M 39.48B
Net Debt -297M -262M -248M -225M -422M -28.54B -426M -2.98B -1.15B -14.57B -1.12B -1.09B -46.89B -601M -530M -502M -455M -853M -57.64B -861M -6.02B -2.32B -29.43B -2.26B -2.21B -94.71B
Logo MiniMed Group, Inc.
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Employees
-
Date Price Change Volume
26-09-30 US$19.75 -1.47% 158,072
26-09-29 US$20.04 -2.20% 3,344,592
26-09-28 US$20.49 +2.55% 3,730,150
26-09-25 US$19.98 -2.25% 2,554,395
26-09-24 US$20.44 -0.49% 3,414,094
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
20.04USD
Average target price
24.92USD
Spread / Average Target
+24.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MMED Stock